UCLA Jonsson Comprehensive Cancer Center

University of California Los Angeles

Los Angeles, CA
Website
(888) 803-1766

Sorting 2 by

Accepting patients

AG-946

A Study of Tebapivat (AG-946) in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS)
Learn more
  • Pyruvate Kinase
  • Phase 2
  • Has results

Accepting patients

R289

Phase 1b Study of R289 in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS)
Learn more
  • IRAK 1 Inhibitor
  • IRAK 4 Inhibitor
  • Phase 1/2